Aug 8, 20191 minBoustead's Dan McClory Talks China Trade Deals on i24NEWS' CrossroadsDan McClory, Managing Director and Head of China & Equity Capital Markets at Boustead Securities, discusses the latest with US and China trade deals with Eri...
Aug 7, 20191 minBoustead's Dan McClory on the impact of China's yuan drop and the US-China trade warDaniel McClory, Managing Director and Head of China & Equity Capital Markets at Boustead Securities speaks with CGTN'S Sean Callebs about the impact of China...
Jul 31, 20191 minBoustead Securities visits client PetCure Oncology's Lakeshore (WI) ClinicBoustead Securities visits PetCure Oncology's Lakeshore (WI) Clinic to meet key team members using the Varian linear accelerator to treat tumors in pets via ...
Jul 23, 20194 minBoustead IPO Client Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial ProtocoBoustead Securities, LLC, IPO client Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a new and proprietary platform...
Jul 19, 20194 minBoustead Client Aerkomm Approved for Secondary Listing on Euronext ParisTrading Scheduled to Begin Tuesday July 23 Boustead Securities, LLC client Aerkomm Inc. (OTCQX: AKOM; Euronext Paris: AKOM), a development stage service prov...
Jul 11, 20193 minBlackboxstocks, Inc. Engages Boustead Securities and Announces $2.2M Private Placement OfferingBoustead Securities client Blackboxstocks Inc. (OTC PINK: BLBX) (“Blackbox”), a developer of real-time web and mobile based analytical software tools for sto...
Jul 9, 20194 minPetCure Oncology Engages Boustead Securities, LLC for Regulation D 506(C) OfferingPetCure Oncology, LLC, a company providing veterinary cancer treatment utilizing noninvasive stereotactic radiosurgery (SRS) and stereotactic radiation thera...
Jul 1, 20197 min Immunotherapy – Aiming To Give The Immune System The Upper Hand In The Fight Against CancerBesides attacking foreign invaders – parasites and pathogenic bacteria and viruses – our immune system also vigilantly patrols the body on the lookout for fo...
Jun 20, 20194 minBoustead IPO Client Soliton Closes $9.45 Million Private PlacementBoustead Securities, LLC, IPO client Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a new and proprietary platform...
